Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abdominal Aortic Aneurysm Risk Factors
Recent studies from University of Texas, Department of Surgery add new data to abdominal aortic aneurysm risk factors
July 10th, 2007
Fresh data on abdominal aortic aneurysm are presented in the report "Endovascular aortic aneurysm repair in patients with the highest risk and in-hospital mortality in the United States." According to recent research from the United States, "A randomized clinical trial from the United Kingdom (EVAR trial 2) comparing endovascular aortic aneurysm repair (EVAR) with no intervention found no advantage for EVAR in patients with high risk. This finding was predominantly caused by the substantial in-hospital mortality after EVAR (9%). The nationwide in-hospital mortality for patients with the highest risk undergoing EVAR in the United States is lower than that reported in EVAR trial 2. based,...
Source: Drug Law Weekly (2007-07-10)
|
|
Advertisement |
|
|
|
